baber/WOPTO huggingface dataset:
Patent AU-2001264696-B2 (AU)
Title: Gene detection assay for improving the likelihood of an effective response to an ErbB antagonist cancer therapy
Inventor: MASS ROBERT D
IPC: C12Q1/6886
Filed: 2001-05-18
Granted: 2007-01-04
Abstract: The invention provides a method for more effective treatment of patients susceptible to or diagnosed with tumors overexpressing ErbB, as determined by a gene amplification assay, with an ErbB antagonist. Such method comprises administering a cancer-treating dose of the ErbB antagonist, preferably in addition to chemotherapeutic agents, to a subject in whose tumor cells ErbB has been found to be amplified e.g., by fluorescent  in situ  hybridization. ErbB antagonists described include an anti-HER2 antibody. Pharmaceutical packaging for providing the components for such treatment is also provided.
Patent AU-2002227958-B2 (AU)
Title: Use of moulding compounds for producing treatment devices
Inventor: FREY OLIVER
IPC: A61K6/90
Filed: 2001-11-29
Granted: 2006-03-02
Abstract: A method for treating hard tissue infection in a site-specific manner, comprising preparing a negative mold of the hard tissue using an impression material which contains a diagnostic additive which generates an identifiable signal on contact with infected tissue; applying a treatment agent to the negative mold at one or more of infected sites; and re-applying the negative mold on the originally molded hard tissue for a suitable period of time. Also disclosed are methods for making the negative mold, a mouthpiece corresponding to the negative mold, and a treatment device, as well as the treatment device and mouthpiece so produced.
Patent AU-2002238397-B2 (AU)
Title: Method for representing and optimising a double-progressive spectacle lens
Inventor: ALTHEIMER HELMUT
IPC: G02C7/02
Filed: 2002-02-04
Granted: 2006-01-12
Abstract: A method for representing and optimizing a double-progressive spectacle lens is characterized by the following steps: selecting a suitable coordinate system K2 for the representation of a back surface; selecting a suitable grid G for the representation of a spline of the back surface of a starting lens to be optimized in a coordinate system K2; assigning sagittal height data of the back surface to a spline (back surface spline); defining a position of a center of rotation of an eye; computing principal rays from the center of rotation of the eye through the starting lens at grid points of G; computing a length of a distance between points of penetration of a thus computed principal ray through a front surface and the back surface (oblique thickness); assigning data of the oblique thickness (thickness spline) to a spline; selecting a set of assessment positions at which an optical quality is computed for a target function; suitably selecting particular optical and geometrical stipulations which ideally should be satisfied at the assessment positions; defining the target function as a deviation of the quality of an actual spectacle lens from ideal values; starting the optimization; evaluating at each one of optimization steps the optical properties in a wearing position at the assessment points by means of surface properties to be computed and actual principal ray data; ending the optimization when the target function is below a particular value, or after a specifiable maximum number of optimization steps.
Patent AU-2002250071-B2 (AU)
Title: Vaccine for transcutaneous immunization
Inventor: CASSELS FREDERICK J
IPC: A61K9/70
Filed: 2002-02-13
Granted: 2008-02-14
Abstract: A vaccine delivered by transcutaneous immunization provides an effective treatment against infections by pathogens such as, for example, enterotoxigenic Escherichia coli (ETEC) and/or for symptoms of diarrheal disease caused thereby. For example, one, two, three, four, five or more antigens derived from ETEC and capable of inducing an antigen-specific immune response (e.g., toxins, colonization or virulence factors) and one or more optional adjuvant (e.g., whole bacterial ADP-ribosylating exotoxins, B subunits or toxoids thereof, detoxified mutants and derivatives thereof) are used to manufacture vaccines or to induce systemic and/or mucosal immunity.
Patent AU-2002252361-B2 (AU)
Title: Method of delaying ejaculation
Inventor: BAR-OR DAVID
IPC: A61K31/137
Filed: 2002-03-15
Granted: 2005-09-08
Abstract: The invention provides a method of delaying ejaculation. The method comprises administering an effective amount of a tramadol material to a human male prior to sexual intercourse. The method is particularly useful for treating premature ejaculation.
Patent AU-2002312982-B2 (AU)
Title: Substituted oxazolidinones for combinational therapy
Inventor: PERZBORN ELISABETH
IPC: A61K31/435
Filed: 2002-06-07
Granted: 2008-01-24
Abstract: The invention relates to combinations of A) oxazolidinones of formula (I) and B) other active ingredients, to a method for producing said combinations and to the use thereof as medicaments, in particular for the treatment and/or prophylaxis of thrombo-embolic diseases.
Patent AU-2003203556-B2 (AU)
Title: Distal component for wrist prosthesis
Inventor: PASCAUD RAPHAEL
IPC: A61F2/00
Filed: 2003-03-28
Granted: 2008-10-23
Abstract: A distal component (24) for a wrist prosthesis includes an ovoid fixation plate (38) having three holes (52,54,56) and a boss. The three holes (52,54,56) allow attachment of stems (42) and/or screws distally for fixation in the carpus. The boss projects proximally from the plate, and serves as an attachment point for the articulating head (32). Modularity of the fixation and articulating components allow a surgeon many options for optimizing fixation distally, and articulation proximally. The proximal head of the distal component is designed to articulate with existing radial components. Since the proximal head of the distal component (24) is modular, however, the head can be redesigned to accommodate later design changes in proximal components. <IMAGE>
Patent AU-2003240432-B2 (AU)
Title: Flocculation with divalent salt
Inventor: THWAITES ERIC
IPC: C08B37/08
Filed: 2003-06-19
Granted: 2008-10-02
Abstract: A method of flocculating a micro-organism and/or removal of high molecular weight contaminants from a fermentation broth, comprising adding a divalent salt to the fermentation broth comprising a glycosaminoglucan of interest after which the micro-organism and/or the high molecular weight contaminants are removed, wherein said micro-organism produces the glycosaminoglucan of interest.
Patent AU-2003260220-B2 (AU)
Title: Universal teeth prosthesis and method of manufacture thereof
Inventor: FORTIN YVAN
IPC: A61C8/00
Filed: 2003-08-25
Granted: 2009-03-12
Abstract: A teeth prosthesis for mounting thereon a member having a set of teeth has at least three implants, each implant having opposite ends, one end of each implant being anchored in a bone of a maxilla while an opposite end projects out of a gingiva and defines a head. A customized connecting bar is also provided, the connecting bar being shaped and sized to substantially conform to and face the gingiva and fastened to the implants. A pair of mating bars having standardized sizes and shapes are also provided, consisting of a meso-bar fastened to the connecting bar and an iso-bar removably attached to the meso-bar through an attachment. The teeth prosthesis of the present invention is more economical to produce than prior art devices since it makes use of customized components and only the connecting bar is adjusted for a specific person.
Patent AU-2003260736-B2 (AU)
Title: A pharmaceutical composition
Inventor: ARMSTRONG DAVID NIGEL
IPC: A61P1/04
Filed: 2003-08-22
Granted: 2009-04-02
Abstract: A topical composition comprising about 5 wt % to about 12.5 wt % of metronidazole or a pharmacologically acceptable salt thereof in a non-aqueous vehicle. The composition may be used in the treatment of skin damage due to inflammatory skin conditions; thermal, chemical or electrical burns; infections or radiation treatment. One advantage of the composition is that topical administration of metronidazole results in a primarily local effect, and thus, side effects observed from systemic administration are avoided.
Patent AU-2004202463-B2 (AU)
Title: Process for grafting a fluoropolymer and multilayer structures comprising this grafted polymer
Inventor: BONNET ANTHONY
IPC: B32B27/30
Filed: 2004-06-03
Granted: 2006-03-16
Abstract: Grafting an unsaturated monomer onto a fluoropolymer comprises mixing the molten fluoropolymer with the monomer, forming the mixture into films, sheets, granules or powder, exposing the products to gamma or beta radiation (1-15 Mrad) in the absence of oxygen and optionally removing any ungrafted monomer. Independent claims are also included for: (1) structures comprising at least one layer of a grafted fluoropolymer produced as above and at least one layer of another material; and (2) bulk-grafted fluoropolymer.
Patent AU-2004293118-B2 (AU)
Title: Neck brace
Inventor: LEATT CHRISTOPHER JAMES
IPC: A61F5/055
Filed: 2004-11-26
Granted: 2009-02-26
Abstract: A neck brace (10) is disclosed which comprises two sections (12,14) which are releasably connected to one another along a split line (18). The ring has upwardly facing surfaces (30,17.1,20.2) which limit tilting movement of a helmeted head in all directions. The brace further has a column (67,70) which extends downwardly from the ring for transferring loads to the wearer's back on each side of the spine.
Patent AU-2004297269-B2 (AU)
Title: Use of bis-amines to enhance the antimicrobial activity of aqueous compositions
Inventor: SCHLITZER RONALD L
IPC: A01N33/04
Filed: 2004-12-09
Granted: 2010-11-18
Abstract: The use of bis-amines to enhance the antimicrobial activity of pharmaceutical compositions is described. The bis-amines are particularly useful for enhancing the antimicrobial activity of aqueous ophthalmic compositions, such as artificial tears or ocular lubricants, and solutions for disinfecting contact lenses.
Patent AU-2005208012-B2 (AU)
Title: Method for the production of a security layer structure, security layer structure, and identification documents containing such a security layer structure
Inventor: RIETZLER MANFRED
IPC: B44F1/12
Filed: 2005-01-28
Granted: 2010-06-10
Abstract: Production of a security layered structure for identification documents.
Patent AU-2005305853-B2 (AU)
Title: Device and method for determining material properties by means of HPLC (High Performance Liquid Chromatography)
Inventor: RADTKE JORG
IPC: B01L99/00
Filed: 2005-11-11
Granted: 2010-08-12
Abstract: An assembly for determining material properties and/or material concentrations of components of a sample, containing: a chromatographic separating column with a liquid mobile solvent; means for controlling the temperature inside the separating column between room temperature and 250° C.; means for creating a pressure level which is greater than ambient pressure inside the separating column; and a detector with a sample volume adapted to insert the components of the sample, is characterized in that the mobile solvent contains water to a large extent; means are provided for expanding the mobile solvent from the increased pressure level inside the separating column to the ambient pressure and for producing a phase change of the mobile solvent from the liquid to gaseous state; and means are provided for transferring the gaseous mobile solvent containing the components of the sample into the sample volume of the detector.
Patent AU-2006236457-B2 (AU)
Title: Process for the production of animal feed and ethanol and novel animal feed
Inventor: SOLHEIM LEIF P
IPC: A23L7/104
Filed: 2006-04-18
Granted: 2012-12-20
Abstract: A method for the production of ethanol and a modified animal feed is provided. The method replaces the starch in known corn-based animal feed with biomass fiber treated to make it more digestible by animals. The process includes wherein the pericarp and germ are removed from the corn kernel and processed for by-products. The starch and protein are also removed and separated. The starch is then fermented and distilled to ethanol and stillage. The bioavailable modified animal feed comprises the pericarp and germ removed from corn kernels and optionally by-products of the pericarp and germ processing, and lignocellulosic materials. The modified animal feed may optionally include energy materials such as animal and vegetable fats, vegetable soapstocks, or glycerin, and combinations thereof.
Patent AU-2006244085-B2 (AU)
Title: Medication safety system featuring a multiplexed RFID interrogator panel
Inventor: HOAG ROBERT E
IPC: G16H40/60
Filed: 2006-05-10
Granted: 2012-12-13
Abstract: A medication safety system includes a panel mounted to an IV pole above a multi- channel infusion pump also mounted to the IV pole. The panel includes multiple RFID readers for reading the RFID tags placed on each of the medication containers mounted to the panel. The pump includes a controller that communicates with the RFID readers at the panel to receive the information read by the RFID readers and automatically program the respective pump channel. A verification program verifies that the medication delivery information from the containers matches the patient identified for the pump and the programming parameters of the pump fall within acceptable ranges. In another aspect, the panel contains multiple vibration devices to impart vibrations to the medication of each of the containers mounted to the panel. Those vibrations are sensed by the particular pumping channel to confirm that the correct channel has been programmed for that medication. When the clinician opens the door of the pumping channel, the pump may request information from the RFID reader at the panel for that medication and may wait for receipt of the vibrations in the medication of the tubing mounted into the channel.
Patent AU-2006249217-B2 (AU)
Title: Apparatus and method for vascular embolization
Inventor: GREENE GEORGE R JR
IPC: A61B17/12
Filed: 2006-12-06
Granted: 2009-01-29
Abstract: Apparatus (10) for deploying an elongate, filamentous embolic device (12; 50) in a vascular site through a catheter (14), the embolic device (12; 50) having a proximal end, the apparatus (10) comprising a flexible, elongate, hollow deployment tube (16) having an axial passage (20) and a distal end; and a holding element (24) that resists radial expansion and that is fixed to the distal end of the deployment tube (16) and configured to hold the proximal end of the embolic device (12; 50) by frictional engagement, the holding element (24) having a base with an opening (26) that communicates with the axial passage (20); and method of deploying an elongate, filamentous embolic device (12; 50) in a vascular site.
Patent AU-2006257367-B2 (AU)
Title: Security document
Inventor: SCHAEDLER RENE
IPC: B42D15/10
Filed: 2006-06-09
Granted: 2009-09-03
Abstract: Described is a security document with a transparent security element (12) which is arranged in a window or in a transparent region of the security document and has a structure layer, in which a first region (12f) of the structure layer has an asymmetrical diffractive relief structure, wherein the first region (12f) has an optical effect which is unexpectedly different in a front view and in a rear view of the security document.
Patent AU-2006260844-B2 (AU)
Title: Method for preparing a fermented beverage with low alcohol content
Inventor: CHELLE RENE
IPC: C12G3/08
Filed: 2006-06-14
Granted: 2010-09-09
Abstract: The preparation of wine with low alcohol content comprises filtering yeast from the wine using filtration unit (8). Relative volumes of fractions of fruit juice are proportional to the final degree of alcohol and final proportion of sugar of the wine. The sugar fraction of the juice is entirely consumed in aerobic culture reactor (1). The yeast concentration in the aerobic culture reactor is 45 g/l. The fractions of fruit juice are introduced into the aerobic culture reactor using introduction unit and are transferred into anaerobic fermentation reactor (2) using transfer unit. The preparation of wine with low alcohol content comprises filtering yeast from the wine using filtration unit (8). Relative volumes of fractions of fruit juice are proportional to the final degree of alcohol and final proportion of sugar of the wine. The sugar fraction of the juice is entirely consumed in aerobic culture reactor (1). The yeast concentration in the aerobic culture reactor is 45 g/l. The fractions of fruit juice are introduced into the aerobic culture reactor using introduction unit and are transferred into anaerobic fermentation reactor (2) using transfer unit. The yeasts in multiplication phase are yeasts naturally present in the fruit juice or inoculated exogenic yeasts cultivated in the fruit juice to destroy whole or part of its endogenous flora. Nutrients are added in the culture reactor. A maturation reactor (3) is equipped with lining of wood slices (4), and entry of gas mixture loaded with volatile flavors and is maintained at alder temperature 2-10[deg]C. The yeast is filtered by frontal filtration, centrifugation or tangential ultrafiltration. The filtered yeast is reintroduced in the culture reactor or in the fermentation reactor. The transformation of the fractions of fruit juice is carried out in continuous mode at an adjustable speed. Independent claims are included for: (1) a device for preparation of wine with low alcohol content; and (2) wine with low alcohol content.
Patent AU-2006268765-B2 (AU)
Title: Asymmetric reduction of 1,1,1-trifluoroacetone
Inventor: KUPFER ERNST
IPC: C12P7/04
Filed: 2006-06-28
Granted: 2010-12-23
Abstract: The invention relates to a scalable biocatalytic process for the preparation of S-1,1,1-trifluoro-2-propanol with a enantiomeric excess of >99% by asymmetric microbial reduction of 1,1,1-trifluoroacetone with Baker's yeast.
Patent AU-2006299200-B2 (AU)
Title: Mobile partition
Inventor: JAN-GERD BEHRENS
IPC: E04B2/82
Filed: 2006-09-12
Granted: 2011-08-18
Abstract: The invention relates to a mobile partition comprising a plurality of wall elements (1) suspended on runners. The aim of the invention is to provide a general-purpose mobile partition which is easy to manufacture and mount and allows for simple and variable possibilities for optionally preparing it for use together with add-on pieces. For this purpose, the wall elements (1) are configured without load-carrying frames and mounting elements (9, 9') are arranged horizontally and/or vertically on the edges of the wall elements (1).
Patent AU-2006329614-B2 (AU)
Title: Method and device for strapping goods
Inventor: FINZO FLAVIO
IPC: B65B11/32
Filed: 2006-12-22
Granted: 2010-07-29
Abstract: In a method to seal/lock a strap (44) including a metal strap (44d) which is fitted at least in the zone of seal with a protective layer (44c), the packing strap is laid in the form of a loop around the package and is held, in particular, clamped, in place before and/or during production of the seal. The seal is implemented on the packing strap (44) by resistance welding and the protective layer (44c) of the packing strap (44) shall be pierced before and/or during production of the seal.
Patent AU-2006337399-B2 (AU)
Title: Suctioning system, method and kit
Inventor: ADAHAN CARMELI
IPC: F04B45/053
Filed: 2006-11-08
Granted: 2013-07-04
Abstract: A suction head in fluid communication with a pump head provides a sub- ambient working pressure to a target area, enabling drainage thereof to a waste container. The pump head is coupled non-mechanically to a pump drive. A control system for a suction system is also provided.
Patent AU-2007209722-B2 (AU)
Title: Recombinant human EPO-Fc fusion proteins with prolonged half-life and enhanced erythropoietic activity in vivo
Inventor: XU JING
IPC: C07K16/18
Filed: 2007-01-25
Granted: 2012-07-26
Abstract: A recombinant fusion protein comprising a human erythropoietin peptide portion linked to an immunoglobulin peptide portion is described. The fusion protein has a prolonged half-life in vivo in comparison to naturally occurring or recombinant native human erythropoietin. In one embodiment of the invention, the protein has a half-life in vivo at least three fold higher than native human erythropoietin. The fusion protein also exhibits enhanced erythropoietic bioactivity in comparison to native human erythropoietin. In one embodiment, the fusion protein comprises the complete peptide sequence of a human erythropoietin (EPO) molecule and the peptide sequence of an Fc fragment of human immunoglobulin IgG1. The Fc fragment in the fusion protein includes the hinge region, CH2 and CH3 domains of human immunoglobulin IgG1. The EPO molecule may be linked directly to the Fc fragment to avoid extraneous peptide linkers and lessen the risk of an immunogenic response when administered in vivo. In one embodiment the hinge region is a human Fc fragment variant having a non-cysteine residue at amino acid 6. The invention also relates to nucleic acid and amino acid sequences encoding the fusion protein and transfected cell lines and methods for producing the fusion protein. The invention further includes pharmaceutical compositions comprising the fusion protein and methods of using the fusion protein and/or the pharmaceutical compositions, for example to stimulate erythropoiesis in subjects in need of therapy.
Patent AU-2007216793-B2 (AU)
Title: Higher performance sleeved interference fasteners for composite applications
Inventor: MARCH MICHAEL U
IPC: F16B35/00
Filed: 2007-09-14
Granted: 2010-04-22
Abstract: A fastener adapted to pass through aligned holes through workpieces is disclosed. The fastener includes a pin member (15) having a transition portion (55) wherein the diameter of the transition portion decreases radially as it extends from the smooth cylindrical shank portion (45) to the threaded portion (50). The fastener may also comprise a sleeve member (20) and a clamping means. The clamping means includes a collar (200), a nut, or any other possible clamping means. In exemplary embodiments, the workpieces can be formed with a plurality of materials, the materials including composite, metallic, or composite/metallic structures, any combination thereof. In particular embodiments, the fastener has interference capability of 0,013 to 0,25 mm (0.0005 to 0.0100 inches) in composite structures without risk of composite delamination or damage. As a result of the fastener interference, gaps between the fastener and the structure are eliminated thereby providing good electrical conductivity between components. As a result, the potential for electrical sparks is reduced, providing a safer fastener for use with aerospace applications.
Patent AU-2007221749-B2 (AU)
Title: Retrofit jig system for a truss assembly table
Inventor: POGUE GREGORY W
IPC: E04G21/16
Filed: 2007-10-01
Granted: 2012-04-12
Abstract: The invention is directed toward a retrofit jig system for use with an existing truss assembly table having multiple planks extending lengthwise along the table. The jig system includes a motor and jig assembly for moving a puck lengthwise along the truss assembly table between adjacent planks of the table. A support member supports the screw between the adjacent planks. The support member is adjustable to allow the puck to move past the support member without interference. N \Mclboumc\Cases\Patent\74000-74999\P74329ALU\Specis\P74329 AU GH Speci as filed doc 1/10/07 co '144 rNN
Patent AU-2007240284-B2 (AU)
Title: Virtual inline configuration for a network device
Inventor: BUDHANI HASEEB
IPC: H04L29/08
Filed: 2007-04-24
Granted: 2012-03-15
Abstract: A performance enhancing proxy network device (110) is configured to operate in a virtual inline mode, in which selected network traffic is redirected to and through the network device (110) by a router (120) using simple routing policies. In this way, the network device (110) can be coupled to the router in parallel but can still operate as if it were physically connected inline.